News
FDA approves new drug to manage menopausal hot flashes
Fezolinetant (Veozah) targets the neural activity behind moderate to severe vasomotor symptoms.
Opinion
A healthy 36-year-old female presented with 4 days of itchy lesions on the right upper extremity
The patient had no systemic symptoms, but did have mild lymphadenopathy.
News
CGM completes picture of A1c in type 2 diabetes
“This may help empower people with diabetes to better manage their condition, giving them practical insights into the factors driving daily...
News
Key red flags for early-onset colorectal cancer
Two symptoms in particular – rectal bleeding and iron-deficiency anemia – point to the need for timely endoscopy and follow-up.
News
ChatGPT delivers credible answers to colonoscopy queries
"This study shows that a conversational AI program can generate credible medical information in response to common patient questions."
News
T-DXd for HER2-low BC: Analysis confirms adverse effects
But T-DXd demonstrates a manageable safety profile consistent with prior reports, says the author of a new paper.
News
At-home monitoring device can predict Crohn’s disease flares
A new device developed at Massachusetts Institute of Technology shows promise.
News
Fewer discontinuations with infliximab vs. vedolizumab for UC maintenance therapy
Findings are based on a pooled analysis of six randomized controlled trials from the past 10 years.
Article
Severe rash after COVID-19 vaccination
The patient’s recent vaccine was the most remarkable thing about his medical history.
Article
What BP target is appropriate for pregnant patients with mild chronic hypertension?
Active treatment to a lower blood pressure goal (< 140/90 mm Hg) can improve pregnancy outcomes without increasing maternal or fetal risk.